Key result
Overexpression of miR-141-3p or silencing of STAT4 reduced the heart weight-to-body weight ratio, improved cardiac function, and alleviated inflammation in EAM mice.
Why the study?
Autoimmune myocarditis is a major cause of heart failure, and microRNAs have been implicated in inflammation and autoimmunity, prompting investigation into how miR-141-3p influences experimental autoimmune myocarditis.
Does overexpression of miR-141-3p or silencing of STAT4 alleviate inflammation and improve cardiac function in mice with experimental autoimmune myocarditis?
Does overexpression of miR-141-3p or silencing of STAT4 alleviate inflammation and improve cardiac function in mice with experimental autoimmune myocarditis?
Upregulation of miR-141-3p alleviates the inflammatory response in experimental autoimmune myocarditis mice by inhibiting STAT4, providing a potential molecular target for treatment.
Answers are grounded in this paper and cite their sources.
May identify miR-141-3p/STAT4 axis in murine myocarditis; leaves open translation to human disease.
As an inflammatory disease afflicting the heart muscle, autoimmune myocarditis (AM) represents one of the foremost causes of heart failure. Accumulating evidence has implicated microRNAs (miRNAs) in the process of inflammation and autoimmunity. Hence, the current study aimed to investigate the mechanism by which miR-141-3p influences experimental AM (EAM). An EAM mouse model was established using 6-wk old male BALB/c mice, after which the expression of miR-141-3p and STAT4 was measured. Gain-of-function and loss-of-function investigations were performed to identify the functional role of miR-141-3p and STAT4 in EAM. Heart weight-to-body weight ratio, cardiac function, and degree of inflammation, as well as the levels of inflammation factors (IFN-γ, TNF-α, IL-2, IL-6, and IL-17) in the serum were detected. STAT4 was subsequently verified to be upregulated, and miR-141-3p was downregulated in the EAM mice. Furthermore, the overexpression of miR-141-3p or silencing of STAT4 was observed to reduce the heart weight-to-body weight ratio of EAM mice and improve cardiac function, while alleviating the degree of inflammatory cell infiltration in the myocardial tissue. Meanwhile, the overexpression of miR-141-3p was identified to diminish serum inflammatory factor levels by downregulating STAT4. Additionally, miR-141-3p could bind to STAT4 to downregulate its expression, ultimately mitigating inflammation and inducing an anti-inflammatory effect in EAM mice. Taken together, upregulation of miR-141-3p alleviates the inflammatory response in EAM mice by inhibiting STAT4, providing a promising intervention target for the molecular treatment of AM. NEW & NOTEWORTHY miR-141-3p is poorly expressed, and STAT4 is upregulated in experimental autoimmune myocarditis (EAM) mice. Overexpressing miR-141-3p inhibits EAM. miR-141-3p binds to and suppresses STAT4 expression. miR-141-3p overexpression inhibits inflammatory factors by downregulating STAT4. This study provides new insights into the treatment of autoimmune myocarditis.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2019) studied Experimental autoimmune myocarditis. miR-141-3p overexpression or STAT4 silencing was evaluated on Heart weight-to-body weight ratio, cardiac function, and degree of inflammation. Overexpression of miR-141-3p or silencing of STAT4 reduced the heart weight-to-body weight ratio, improved cardiac function, and alleviated inflammation in EAM mice.
Synapse has enriched 10 related papers. Consider them for comparative context: